A remarkable new breakthrough in skin repair.
Skin damage as a result of sun exposure is a common and serious problem. Wrinkles, sagging skin, rough skin tone, mottled pigmentation, and sallow
skin are all some common cosmetic concerns relating to sun exposure. However, more serious concerns such as skin cancer and actinic keratosis should
also be addressed in a serious, effective skin care routine.
The NIA 24/7 Skin System by Niadyne, Inc. has found a remarkable new treatment that has been shown to repair skin DNA cells damaged by sun
exposure. This new DNA repair technology is so promising, and the early findings so impressive, the National Cancer Institute of the National
Institutes of Health has selected this technology to be developed as a potential skin cancer prevention agent.
Pro-NAD simultaneously increases skin cell turnover and skin barrier integrity - unlike other anti-aging products, Pro-NAD showed an ability to
significantly increase cell turnover without weakening the skin barrier. In fact, the skin barrier was strengthened, resulting is less moisture-loss
and increased photoprotection.
Skin roughness improved in 82% of study subjects - After 30 days, significant improvement was observed, with continued progress through the 90
trial period. The degree of improvement was strongly correlated with the degree of photodamage. In addition to reduction of tactile roughness, an
unexpected but significant reduction in solar lentigines was also observed.
Skin firmness improved in 52% of study subjects - Improvements in skin firmness were greatest in subjects with severe photodamage. Significant
improvements were observed in the cheek and jaw regions at 30 days, and improvements were significant in all regions by 60 days.
Skin tone improved in 81% of study subjects - Significant improvement in skin color and radiance contributing to skin tone was observed in all
regions by 30 days, and improvement progressed linearly over the 90-day trial period.
Fine lines and wrinkles improved in 68% of study subjects.
Pro-NAD has been chosen by the National Cancer Institute (NCI) of the National Institutes of Health for development as a skin cancer